Arming CTLs against immunosuppressors

Research output: Contribution to journalArticle

Abstract

Cell therapy efficacy after organ transplantation is hampered by the detrimental effects of pharmacologic immunosuppression on T-cell expansion and function. In this issue of Blood, 2 independent groups describe genetic engineering of ex vivo expanded EBV-CTLs to induce calcineurin-inhibitor resistance.

Original languageEnglish
Pages (from-to)4759-4760
Number of pages2
JournalBlood
Volume114
Issue number23
DOIs
Publication statusPublished - Nov 26 2009

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Immunology
  • Hematology

Fingerprint Dive into the research topics of 'Arming CTLs against immunosuppressors'. Together they form a unique fingerprint.

  • Cite this